These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 8011749)

  • 1. Combination cytokine therapy in cancer.
    Ernstoff MS
    Immunol Ser; 1994; 61():273-9. PubMed ID: 8011749
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of cytokine therapy in 2006 and beyond for metastatic renal cell cancer.
    Parton M; Gore M; Eisen T
    J Clin Oncol; 2006 Dec; 24(35):5584-92. PubMed ID: 17158544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multi-cytokine therapy for advanced renal cell carcinoma: determination of the minimal effective dose.
    Hamada I; Kato M; Okada K
    Anticancer Res; 2002; 22(4):2429-36. PubMed ID: 12174939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of clinical and immunological parameters of metastatic renal cell carcinoma patients undergoing therapy with interleukin 2, interferon-alpha and retinoic acid.
    Elsässer-Beile U; Kölble N; Grussenmeyer T; Wetterauer U; Schultze-Seemann W
    Anticancer Res; 1998; 18(3B):1883-90. PubMed ID: 9677439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Tumor reduction in advanced renal cell carcinoma with tumor thrombus by renal embolization, interferon-alpha and UFT. A case report].
    Shiomi K; Kamura K; Seto K; Hamaguchi K; Matsushita K; Yamauchi T
    Hinyokika Kiyo; 1997 Mar; 43(3):217-21. PubMed ID: 9127758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Long-term complete response of multiple lung metastases from renal cell carcinoma induced by combination therapy with interferon alpha and UFT: a case report].
    Terachi T; Okada Y; Takeuchi H; Yoshida O
    Hinyokika Kiyo; 1993 Apr; 39(4):353-5. PubMed ID: 8503332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination biologic therapy with interleukin-2 and interferon-alfa in the outpatient treatment of metastatic renal cell carcinoma.
    Figlin RA; Pierce WC; Belldegrun A
    Semin Oncol; 1993 Dec; 20(6 Suppl 9):11-5. PubMed ID: 8284686
    [No Abstract]   [Full Text] [Related]  

  • 8. [Immunotherapeutic treatment for metastatic renal carcinoma].
    Hidalgo Pardo F; Gutiérrez Sanz-Gadea C; Rebassa Llull MJ; García Bueno JM; Mus Malleu A; Losada González GP; Ozonas Moragues M
    Actas Urol Esp; 1998 Jan; 22(1):29-33. PubMed ID: 9542189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Interferon-alpha therapy in hypernephroma].
    Sagaster KP
    Wien Med Wochenschr; 1993; 143(16-17):443-7. PubMed ID: 8273370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokines and cytotoxic agents in renal cell carcinoma: a review.
    Stahl M; Wilke HJ; Seeber S; Schmoll HJ
    Semin Oncol; 1992 Apr; 19(2 Suppl 4):70-9. PubMed ID: 1553577
    [No Abstract]   [Full Text] [Related]  

  • 11. Integrative tumor board: metastatic renal cell carcinoma: medical oncology (II).
    Pandha H
    Integr Cancer Ther; 2004 Mar; 3(1):29-34. PubMed ID: 15035872
    [No Abstract]   [Full Text] [Related]  

  • 12. Whole body hyperthermia in adjuvant therapy of children with renal cell carcinoma.
    Ismail-Zade RS; Zhavrid EA; Potapnev MP
    Pediatr Blood Cancer; 2005 Jun; 44(7):679-81. PubMed ID: 15700247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Three cases of lung metastases of renal cell carcinoma treated with a combination of interferon-alpha, 5-fluorouracil and leucovorin].
    Togashi M; Tabata T; Hirakawa K; Ohashi N; Sindoh J; Hirano T; Demura T
    Hinyokika Kiyo; 1996 Jan; 42(1):43-5. PubMed ID: 8686582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Results of low dosage cyclic interferon-gamma therapy of metastatic renal cell carcinoma].
    Hofmockel G; Wirth MP; Heimbach D; Frohmüller HG
    Urologe A; 1993 Jul; 32(4):290-4. PubMed ID: 8372410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case study of metastatic renal cell carcinoma in lungs showing complete response to continuous subcutaneous injection of interferon alpha and gamma].
    Kawata N; Hirakata H; Igarashi T; Minei S; Hamano K; Kodama M; Yamamoto T; Takimoto Y
    Hinyokika Kiyo; 1996 Jul; 42(7):509-12. PubMed ID: 8809559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of two sequential phase II studies of interleukin-2 (IL2) in metastatic renal cell carcinoma and melanoma: high-dose continuous intravenous IL2 infusion and subcutaneous IL2 administration in combination with alpha interferon.
    Hidalgo OF; Aramendía JM; Alonso G; Foncillas JG; Brugarolas A
    Rev Med Univ Navarra; 1996; 40(3):6-12. PubMed ID: 9499820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Successful management for advanced renal cell carcinoma under combination therapy with human lymphoblastoid interferon-alpha and UFT (mixture of tegafur and uracil): a case report].
    Kanno H; Kitami K; Senga Y; Takahashi T; Nagashima Y
    Hinyokika Kiyo; 1993 Aug; 39(8):725-9. PubMed ID: 8379474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine combinations: therapeutic use in patients with advanced renal cell carcinoma.
    Bukowski RM
    Semin Oncol; 2000 Apr; 27(2):204-12. PubMed ID: 10768599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Various questions concerning the treatment of renal cell carcinoma].
    Ueda T
    Fukuoka Igaku Zasshi; 1990 Jan; 81(1):1-4. PubMed ID: 2108916
    [No Abstract]   [Full Text] [Related]  

  • 20. Progressive anemia following combination therapy with interferon-alpha and interleukin-2 in a patient with metastatic renal cell carcinoma.
    Hosokawa Y; Kishino T; Ono T; Oyama N; Hayashi K; Momose H
    Int J Urol; 2004 Oct; 11(10):906-8. PubMed ID: 15479299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.